{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:41:16Z","timestamp":1793947276308,"version":"4.8.0"},"reference-count":294,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2019056"],"award-info":[{"award-number":["2019056"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FT190100572"],"award-info":[{"award-number":["FT190100572"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["IH220100017"],"award-info":[{"award-number":["IH220100017"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jconrel.2026.114838","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:00:36Z","timestamp":1773763236000},"page":"114838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Poly(2-oxazoline) and poly(2-oxazine)-based nanomedicines: Advancements, opportunities and challenges"],"prefix":"10.1016","volume":"394","author":[{"given":"James","family":"Humphries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Warne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlagh M.","family":"Feeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristofer J.","family":"Thurecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Kempe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1461-5347(00)00255-8","article-title":"Therapeutic applications of colloidal drug carriers","volume":"3","author":"Barratt","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"issue":"33","key":"10.1016\/j.jconrel.2026.114838_bb0010","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1016\/j.biomaterials.2011.07.057","article-title":"Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles","volume":"32","author":"Vrignaud","year":"2011","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4155\/bio.11.304","article-title":"Metabolism of biologics: biotherapeutic proteins","volume":"4","author":"Hamuro","year":"2012","journal-title":"Bioanalysis"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharmacol. Ther. (St. Louis, MO, U. S.)"},{"issue":"9","key":"10.1016\/j.jconrel.2026.114838_bb0025","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114838_bb0030","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/138945006777435245","article-title":"Nanoparticle-based diagnosis and therapy","volume":"7","author":"David","year":"2006","journal-title":"Curr. Drug Targets"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s40204-018-0095-0","article-title":"Cellulose-based hydrogel materials: chemistry, properties and their prospective applications","volume":"7","author":"Kabir","year":"2018","journal-title":"Progr. Biomater."},{"key":"10.1016\/j.jconrel.2026.114838_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mser.2018.01.002","article-title":"Naturally-derived biopolymer nanocomposites: interfacial design, properties and emerging applications","volume":"125","author":"Xiong","year":"2018","journal-title":"Mater. Sci. Eng. R. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12951-025-03113-7","article-title":"A systematic review of nanocarriers used in medicine and beyond \u2014 definition and categorization framework","volume":"23","author":"Gressler","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114838_bb0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nmat2442","article-title":"Understanding biophysicochemical interactions at the nano\u2013bio interface","volume":"8","author":"Nel","year":"2009","journal-title":"Nat. Mater."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114838_bb0065","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.114838_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2016.05.029","article-title":"The early days of PEG and PEGylation (1970s-1990s)","volume":"40","author":"Hoffman","year":"2016","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0005-2795(79)90111-9","article-title":"Preparation of a non-immunogenic arginase by the covalent attachment of polyethylene glycol","volume":"578","author":"Savoca","year":"1979","journal-title":"Biochim. Biophys. Acta (BBA) - Protein Struct."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114838_bb0080","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1016\/S0021-9258(17)40291-2","article-title":"Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.114838_bb0085","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2147\/IJN.S38378","article-title":"Nanodrugs: pharmacokinetics and safety","volume":"9","author":"Onoue","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10717540600814402","article-title":"Pharmacokinetic consequences of Pegylation","volume":"13","author":"Hamidi","year":"2006","journal-title":"Drug Deliv."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb0095","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine (London)"},{"issue":"42","key":"10.1016\/j.jconrel.2026.114838_bb0100","doi-asserted-by":"crossref","first-page":"13873","DOI":"10.1002\/anie.201808615","article-title":"Revealing the immunogenic risk of polymers","volume":"57","author":"Li","year":"2018","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J. Control. Release"},{"issue":"Pt B","key":"10.1016\/j.jconrel.2026.114838_bb0110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","article-title":"Anti-PEG antibodies in the clinic: current issues and beyond PEGylation","volume":"244","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114838_bb0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/polym12020298","article-title":"The importance of poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation","volume":"12","author":"Hoang Thi","year":"2020","journal-title":"Polymers (Basel)"},{"issue":"18","key":"10.1016\/j.jconrel.2026.114838_bb0120","doi-asserted-by":"crossref","first-page":"2000319","DOI":"10.1002\/marc.202000319","article-title":"Next-generation polymeric nanomedicines for oncology: perspectives and future directions","volume":"41","author":"Fletcher","year":"2020","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2026.114838_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101738","article-title":"Poly(ethylene glycol) alternatives in biomedical applications","volume":"48","author":"Yao","year":"2023","journal-title":"Nano Today"},{"issue":"15","key":"10.1016\/j.jconrel.2026.114838_bb0130","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1002\/pola.23448","article-title":"Synthesis and characterization of a series of diverse poly(2-oxazoline)s","volume":"47","author":"Kempe","year":"2009","journal-title":"J. Polym. Sci. A Polym. Chem."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114838_bb0135","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/mabi.201200080","article-title":"Partial hydrolysis of poly(2-ethyl-2-oxazoline) and potential implications for biomedical applications?","volume":"12","author":"Van Kuringen","year":"2012","journal-title":"Macromol. Biosci."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114838_bb0140","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1021\/acs.macromol.5b00290","article-title":"Functional poly(2-oxazoline)s by direct amidation of methyl ester side chains","volume":"48","author":"Mees","year":"2015","journal-title":"Macromolecules"},{"issue":"43","key":"10.1016\/j.jconrel.2026.114838_bb0145","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1002\/anie.200901607","article-title":"Poly(2-oxazoline)s: a polymer class with numerous potential applications","volume":"48","author":"Hoogenboom","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb0150","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1021\/bc200049d","article-title":"Polyoxazoline: chemistry, properties, and applications in drug delivery","volume":"22","author":"Viegas","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2026.114838_bb0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.eurpolymj.2016.10.041","article-title":"POxylation as an alternative stealth coating for biomedical applications","volume":"88","author":"Bludau","year":"2017","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2026.114838_bb0160","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eurpolymj.2016.09.011","article-title":"Poly(2-oxazoline)-based micro- and nanoparticles: a review","volume":"88","author":"Wilson","year":"2017","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2026.114838_bb0165","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.biomaterials.2018.05.022","article-title":"Poly(2-oxazoline)s based biomaterials: a comprehensive and critical update","volume":"178","author":"Lorson","year":"2018","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0170","article-title":"Drug delivery systems based on poly(2-Oxazoline)s and poly(2-oxazine)s","volume":"3","author":"Sedlacek","year":"2020","journal-title":"Adv. Ther."},{"issue":"36","key":"10.1016\/j.jconrel.2026.114838_bb0175","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1002\/anie.201805620","article-title":"Chemical design of non-ionic polymer brushes as biointerfaces: poly(2-oxazine)s outperform both poly(2-oxazoline)s and PEG","volume":"57","author":"Morgese","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.114838_bb0180","doi-asserted-by":"crossref","first-page":"1900168","DOI":"10.1002\/adtp.201900168","article-title":"Drug delivery systems based on poly(2-Oxazoline)s and poly(2-oxazine)s","volume":"3, (1)","author":"Sedlacek","year":"2020","journal-title":"Adv. Ther."},{"issue":"23","key":"10.1016\/j.jconrel.2026.114838_bb0185","doi-asserted-by":"crossref","first-page":"10667","DOI":"10.1021\/acs.macromol.1c01794","article-title":"Self-assembly, drug encapsulation, and cellular uptake of block and gradient copolymers of 2-methyl-2-oxazine and 2-n-propyl\/butyl-2-oxazoline","volume":"54","author":"Babuka","year":"2021","journal-title":"Macromolecules"},{"issue":"24","key":"10.1016\/j.jconrel.2026.114838_bb0190","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1039\/D3PY00399J","article-title":"Length-tuneable biocompatible block copolymer nanorods with a poly(2-methyl-2-oxazine)-corona via heat-induced crystallisation-driven self-assembly","volume":"14","author":"Warne","year":"2023","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jconrel.2026.114838_bb0195","doi-asserted-by":"crossref","first-page":"2402029","DOI":"10.1002\/adhm.202402029","article-title":"Impact of drug conjugation site and corona chemistry on the therapeutic activity of polymer nanorod \u2013 drug conjugates","volume":"13, (31)","author":"Warne","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0200","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1021\/acs.biomac.4c01340","article-title":"The topology of poly(2-methyl-2-oxazine) shells on nanoparticles determines their interaction with serum and uptake by immune cells","volume":"26","author":"Morbidelli","year":"2025","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb0205","doi-asserted-by":"crossref","first-page":"2001382","DOI":"10.1002\/adhm.202001382","article-title":"Poly(2-oxazoline)- and poly(2-oxazine)-based self-assemblies, polyplexes, and drug nanoformulations\u2014an update","volume":"10","author":"Zahoranov\u00e1","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb0210","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s13233-023-00116-x","article-title":"Poly(2-oxazoline)s: synthesis and biomedical applications","volume":"31","author":"Yang","year":"2023","journal-title":"Macromol. Res."},{"key":"10.1016\/j.jconrel.2026.114838_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2025.114292","article-title":"Poly(2-oxazoline)-based drug delivery systems for cancer therapy","volume":"239","author":"Kulkarni","year":"2025","journal-title":"Eur. Polym. J."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0220","first-page":"36","article-title":"Polyethylene glycol reactive antibodies in man: Titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors","volume":"74","author":"Richter","year":"1984","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.jconrel.2026.114838_bb0225","first-page":"556A","article-title":"Occurrence of an antibody to poly(ethylene glycol) in normal donors","volume":"102","author":"Armstrong","year":"2003","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.jconrel.2026.114838_bb0230","doi-asserted-by":"crossref","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","article-title":"Analysis of pre-existing IgG and IgM antibodies against polyethylene glycol (PEG) in the general population","volume":"88","author":"Yang","year":"2016","journal-title":"Anal. Chem."},{"issue":"21","key":"10.1016\/j.jconrel.2026.114838_bb0235","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1021\/acs.analchem.6b03109","article-title":"Measurement of pre-existing IgG and IgM antibodies against polyethylene glycol in healthy individuals","volume":"88","author":"Chen","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2026.114838_bb0240","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.toxrep.2020.12.022","article-title":"Flow cytometry analysis of anti-polyethylene glycol antibodies in human plasma","volume":"8","author":"Fang","year":"2021","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.jconrel.2026.114838_bb0245","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2022.12.039","article-title":"Anti-PEG antibodies before and after a first dose of Comirnaty\u00ae (mRNA-LNP-based SARS-CoV-2 vaccine)","volume":"354","author":"Bavli","year":"2023","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114838_bb0250","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s11095-013-1067-7","article-title":"The immunogenicity of polyethylene glycol: facts and fiction","volume":"30","author":"Schellekens","year":"2013","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114838_bb0255","doi-asserted-by":"crossref","first-page":"15723","DOI":"10.1021\/acsnano.0c06679","article-title":"Person-specific biomolecular coronas modulate nanoparticle interactions with immune cells in human blood","volume":"14","author":"Ju","year":"2020","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0260","doi-asserted-by":"crossref","DOI":"10.1186\/ar4500","article-title":"Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients","volume":"16","author":"Hershfield","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb0265","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.jaci.2015.10.034","article-title":"Pre-existing anti\u2013polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer","volume":"137","author":"Ganson","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3324\/haematol.2020.258525","article-title":"Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia","volume":"107","author":"Khalil","year":"2022","journal-title":"Haematologica"},{"issue":"24","key":"10.1016\/j.jconrel.2026.114838_bb0275","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","article-title":"Complement receptor 2\/CD21\u2212 human naive B cells contain mostly autoreactive unresponsive clones","volume":"115","author":"Isnardi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.114838_bb0280","first-page":"3645","article-title":"Tolerance-like innate immunity and spleen injury: a novel discovery via the weekly administrations and consecutive injections of PEGylated emulsions","volume":"9","author":"Wang","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5487\/TR.2015.31.2.105","article-title":"Safety evaluation of polyethylene glycol (PEG) compounds for cosmetic use","volume":"31","author":"Jang","year":"2015","journal-title":"Toxicolog. Res."},{"key":"10.1016\/j.jconrel.2026.114838_bb0290","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jconrel.2023.01.012","article-title":"Investigation of anti-PEG antibody response to PEG-containing cosmetic products in mice","volume":"354","author":"Ibrahim","year":"2023","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0295","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1021\/acs.molpharmaceut.3c00774","article-title":"Impact of anti-PEG IgM induced via the topical application of a cosmetic product containing PEG derivatives on the antitumor effects of PEGylated liposomal antitumor drug formulations in mice","volume":"21","author":"Gaballa","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114838_bb0300","article-title":"Immunobiology of carbohydrates: implications for novel vaccine and adjuvant design against infectious diseases","volume":"11","author":"Stefanetti","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114838_bb0305","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1021\/acsbiomaterials.7b00147","article-title":"Cross-reactivity of select PEG-binding antibodies to other polymers containing a C-C-O backbone","volume":"3","author":"McCallen","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0310","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41577-022-00825-x","article-title":"Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines","volume":"23","author":"Ju","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114838_bb0315","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.jaip.2021.03.002","article-title":"Hidden dangers: recognizing excipients as potential causes of drug and vaccine hypersensitivity reactions","volume":"9","author":"Caballero","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2018.12.003","article-title":"Immediate hypersensitivity to polyethylene glycols and polysorbates: more common than we have recognized","volume":"7","author":"Stone","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jconrel.2026.114838_bb0325","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cocis.2017.07.003","article-title":"The light at the end of the tunnel\u2014second generation HPMA conjugates for cancer treatment","volume":"31","author":"Yang","year":"2017","journal-title":"Curr. Opin. Colloid Interface Sci."},{"issue":"42","key":"10.1016\/j.jconrel.2026.114838_bb0330","doi-asserted-by":"crossref","first-page":"13873","DOI":"10.1002\/anie.201808615","article-title":"Revealing the immunogenic risk of polymers","volume":"57","author":"Li","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.114838_bb0335","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.progpolymsci.2018.01.002","article-title":"Polysarcosine-containing copolymers: synthesis, characterization, self-assembly, and applications","volume":"81","author":"Birke","year":"2018","journal-title":"Prog. Polym. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0340","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/08982109809035531","article-title":"Repeat injection studies of technetium-99M-labeled peg-liposomes in the same animal","volume":"8","author":"Coins","year":"1998","journal-title":"J. Liposome Res."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0345","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes","volume":"292","author":"Dams","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0350","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jconrel.2003.12.011","article-title":"Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice","volume":"95","author":"Ishida","year":"2004","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0355","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2006.08.001","article-title":"Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes","volume":"115","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0360","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2007.05.015","article-title":"PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner","volume":"122","author":"Ishida","year":"2007","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114838_bb0365","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1002\/jps.22682","article-title":"Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance","volume":"100","author":"Kaminskas","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2026.114838_bb0370","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijpharm.2012.07.049","article-title":"Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs","volume":"436","author":"Suzuki","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114838_bb0375","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1021\/acs.molpharmaceut.5b00144","article-title":"Anti-PEG IgM is a major contributor to the accelerated blood clearance of polyethylene glycol-conjugated protein","volume":"12","author":"Mima","year":"2015","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114838_bb0380","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1021\/acs.molpharmaceut.0c00366","article-title":"Impact of pre-existing or induced anti-PEG IgM on the pharmacokinetics of peginterferon alfa-2a (Pegasys) in mice","volume":"17","author":"Elsadek","year":"2020","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114838_bb0385","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0390","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-3659(02)00462-5","article-title":"Accelerated clearance of PEGylated liposomes in rats after repeated injections","volume":"88","author":"Ishida","year":"2003","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0395","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2007.02.010","article-title":"Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes","volume":"119","author":"Wang","year":"2007","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0400","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2007.11.005","article-title":"Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes","volume":"354","author":"Ishida","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0405","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0750-7658(05)81033-0","article-title":"Hapten inhibition of dextran anaphylaxis. Nine years of post-marketing surveillance of dextran 1","volume":"12","author":"Ljungstr\u00f6m","year":"1993","journal-title":"Ann. Fr. Anesth. Reanim."},{"key":"10.1016\/j.jconrel.2026.114838_bb0410","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpb.2020.04.026","article-title":"Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice","volume":"152","author":"Elsadek","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114838_bb0415","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1200\/JCO.1995.13.7.1777","article-title":"Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies","volume":"13","author":"Uziely","year":"1995","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0420","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.1997.15.3.987","article-title":"Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation","volume":"15","author":"Muggia","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0425","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.2002.20.3.727","article-title":"Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III\/IV breast cancer","volume":"20","author":"Holmes","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114838_bb0430","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S0168-8278(10)60309-1","article-title":"High prevalence of pre-existing antibodies against polyethylene glycol (PEG) in hepatitis C (HCV) patients which is not associated with impaired response to PEG-interferon","volume":"52","author":"Tillmann","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2026.114838_bb0435","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.actbio.2020.11.047","article-title":"Alternating stealth polymer coatings between administrations minimizes toxic and antibody immune responses towards nanomedicine treatment regimens","volume":"121","author":"Li","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114838_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.023","article-title":"The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes","volume":"213","author":"Kierstead","year":"2015","journal-title":"J. Control. Release"},{"issue":"30","key":"10.1016\/j.jconrel.2026.114838_bb0445","first-page":"19890","article-title":"Mitigating the effects of persistent antipolymer immune reactions in nanomedicine: evaluating materials-based approaches using molecular imaging","volume":"18","author":"Humphries","year":"2024","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0450","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","article-title":"Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals","volume":"61","author":"Szebeni","year":"2014","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114838_bb0455","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jaip.2020.11.011","article-title":"Anti-PEG IgE in anaphylaxis associated with polyethylene glycol","volume":"9","author":"Zhou","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"28","key":"10.1016\/j.jconrel.2026.114838_bb0460","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1016\/j.vaccine.2023.05.029","article-title":"Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination","volume":"41","author":"Zhou","year":"2023","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0465","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/imj.16605","article-title":"Excipient induced allergies in oral medications: unravelling the covert threat \u2013 a systematic review","volume":"55","author":"Seth","year":"2025","journal-title":"Intern. Med. J."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb0470","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jaip.2018.08.033","article-title":"Polyethylene glycol: not just a harmless excipient","volume":"6","author":"Kennard","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb0475","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.pcl.2015.07.013","article-title":"Mechanisms of Oral tolerance","volume":"62","author":"Commins","year":"2015","journal-title":"Pediatr. Clin. N. Am."},{"issue":"483","key":"10.1016\/j.jconrel.2026.114838_bb0480","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau6753","article-title":"\u201cInactive\u201d ingredients in oral medications","volume":"11","author":"Reker","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"23","key":"10.1016\/j.jconrel.2026.114838_bb0485","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1200\/JCO.18.02439","article-title":"Antibodies predict pegaspargase allergic reactions and failure of rechallenge","volume":"37","author":"Liu","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb0490","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00280-014-2464-2","article-title":"Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginase","volume":"73","author":"Fernandez","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0495","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cncr.22739","article-title":"Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients","volume":"110","author":"Armstrong","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2026.114838_bb0500","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/pbc.26686","article-title":"Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-pharmacokinetics and antibody formation","volume":"64","author":"Tram Henriksen","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb0505","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3899\/jrheum.200460","article-title":"Pegloticase in combination with methotrexate in patients with uncontrolled gout: a multicenter, open-label study (MIRROR)","volume":"48","author":"Botson","year":"2021","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0510","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar4497","article-title":"Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout","volume":"16","author":"Lipsky","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114838_bb0515","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1169","article-title":"Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials","volume":"306","author":"Sundy","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0520","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40744-019-0151-9","article-title":"Use of pre-infusion serum uric acid levels as a biomarker for infusion reaction risk in patients on pegloticase","volume":"6","author":"Keenan","year":"2019","journal-title":"Rheumatol. Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0525","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/bc200551b","article-title":"Role of the methoxy group in immune responses to mPEG-protein conjugates","volume":"23","author":"Sherman","year":"2012","journal-title":"Bioconjug. Chem."},{"issue":"23","key":"10.1016\/j.jconrel.2026.114838_bb0530","doi-asserted-by":"crossref","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","article-title":"Analysis of pre-existing IgG and IgM antibodies against Polyethylene Glycol (PEG) in the general population","volume":"88","author":"Yang","year":"2016","journal-title":"Analytical Chemistry"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114838_bb0535","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb0560","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1074-7613(01)00129-7","article-title":"Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens","volume":"14","author":"Martin","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114838_bb0540","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.021908.132607","article-title":"Human marginal zone B cells","volume":"27","author":"Weill","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"17","key":"10.1016\/j.jconrel.2026.114838_bb0565","doi-asserted-by":"crossref","first-page":"2304033","DOI":"10.1002\/adhm.202304033","article-title":"Substituting poly(ethylene glycol) lipids with poly(2-ethyl-2-oxazoline) lipids improves lipid nanoparticle repeat dosing","volume":"13","author":"Sanchez","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0570","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","article-title":"Germinal center B cell dynamics","volume":"45","author":"Mesin","year":"2016","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0575","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/bjh.16254","article-title":"Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker","volume":"189","author":"Kloos","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114838_bb0580","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1021\/acsnano.9b03942","article-title":"Pseudo-anaphylaxis to polyethylene glycol (PEG)-coated liposomes: roles of anti-PEG IgM and complement activation in a porcine model of human infusion reactions","volume":"13","author":"Kozma","year":"2019","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114838_bb0585","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41565-021-01001-3","article-title":"The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines","volume":"16","author":"Bigini","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114838_bb0590","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement","volume":"341","author":"Estap\u00e9 Senti","year":"2022","journal-title":"J. Controll. Rel. Offl. J. Controll. Releas. Soc."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0595","article-title":"Liposomal amphotericin B and complement activation-related pseudoallergy (CARPA)","volume":"69","author":"Thompson George","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0600","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated liposomes: immunological responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0605","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11357-021-00495-y","article-title":"A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor","volume":"44","author":"D\u00e9zsi","year":"2022","journal-title":"GeroScience"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0610","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejps.2013.03.007","article-title":"Complement activation by PEGylated liposomes containing prednisolone","volume":"49","author":"van den Hoven","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0615","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jconrel.2013.05.030","article-title":"Complement monitoring of Pluronic 127 gel and micelles: suppression of copolymer-mediated complement activation by elevated serum levels of HDL, LDL, and apolipoproteins AI and B-100","volume":"170","author":"Hamad","year":"2013","journal-title":"J. Controll. Rel. Offl. J. Controll. Releas. Soc."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb0620","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1021\/acs.nanolett.0c01011","article-title":"Overcoming nanoparticle-mediated complement activation by surface PEG pairing","volume":"20","author":"Pannuzzo","year":"2020","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0545","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fc\u03b3 receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"24","key":"10.1016\/j.jconrel.2026.114838_bb0550","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.114838_bb0555","series-title":"IgG Subclasses and Allotypes: From Structure to Effector Functions","author":"Vidarsson","year":"2014"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114838_bb0625","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41565-018-0273-1","article-title":"Roadmap and strategy for overcoming infusion reactions to nanomedicines","volume":"13","author":"Szebeni","year":"2018","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0630","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.molimm.2008.08.276","article-title":"Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process","volume":"46","author":"Hamad","year":"2008","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0635","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2025.2494775","article-title":"PEGylation technology: addressing concerns, moving forward","volume":"32","author":"Simberg","year":"2025","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.114838_bb0640","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2024.01.003","article-title":"Development of anti-PEG IgG\/IgM\/IgE ELISA assays for profiling anti-PEG immunoglobulin response in PEG-sensitized individuals and patients with alpha-gal allergy","volume":"366","author":"Li","year":"2024","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0645","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1021\/acssensors.4c03184","article-title":"Multiplexing label-free polymeric nanocarriers via antipolymer antibodies","volume":"10","author":"Humphries","year":"2025","journal-title":"ACS Sens."},{"issue":"115","key":"10.1016\/j.jconrel.2026.114838_bb0650","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ady7328","article-title":"Cross-species cellular mapping and humanization of Fc\u03b3 receptors to advance antibody modeling","volume":"11","author":"Van Damme","year":"2026","journal-title":"Sci. Immunol."},{"issue":"17","key":"10.1016\/j.jconrel.2026.114838_bb0655","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1016\/j.biomaterials.2014.02.029","article-title":"On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s","volume":"35","author":"Ulbricht","year":"2014","journal-title":"Biomaterials"},{"issue":"19","key":"10.1016\/j.jconrel.2026.114838_bb0660","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/marc.201200422","article-title":"Polyoxazolines for nonfouling surface coatings \u2014 a direct comparison to the gold standard PEG","volume":"33","author":"Konradi","year":"2012","journal-title":"Macromol. Rapid Commun."},{"issue":"15","key":"10.1016\/j.jconrel.2026.114838_bb0665","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.addr.2007.08.018","article-title":"Poly(2-oxazolines) in biological and biomedical application contexts","volume":"59","author":"Adams","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"36","key":"10.1016\/j.jconrel.2026.114838_bb0670","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.114838_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111521","article-title":"The future of poly(2-oxazoline)s","volume":"179","author":"Hoogenboom","year":"2022","journal-title":"Eur. Polym. J."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb0680","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1163\/156855505774597704","article-title":"Microwave-assisted synthesis and properties of a series of poly(2-alkyl-2-oxazoline)s","volume":"8","author":"Hoogenboom","year":"2005","journal-title":"Des. Monomers Polym."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0685","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/marc.201100587","article-title":"Thermoresponsive poly(2-oxazine)s","volume":"33","author":"Bloksma","year":"2012","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2026.114838_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2021.110299","article-title":"Poly(2-oxazine)s: a comprehensive overview of the polymer structures, physical properties and applications","volume":"147","author":"Varanaraja","year":"2021","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2026.114838_bb0695","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/pi.5457","article-title":"Poly(2-oxazoline)s: a comprehensive overview of polymer structures and their physical properties","volume":"67","author":"Glassner","year":"2018","journal-title":"Polym. Int."},{"key":"10.1016\/j.jconrel.2026.114838_bb0700","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.eurpolymj.2016.11.016","article-title":"The chemistry of poly(2-oxazoline)s","volume":"88","author":"Verbraeken","year":"2017","journal-title":"Eur. Polym. J."},{"issue":"18","key":"10.1016\/j.jconrel.2026.114838_bb0705","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/marc.201100138","article-title":"Poly(cyclic imino ether)s beyond 2-substituted-2-oxazolines","volume":"32","author":"Bloksma","year":"2011","journal-title":"Macromol. Rapid Commun."},{"issue":"26","key":"10.1016\/j.jconrel.2026.114838_bb0710","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1039\/D4PY00332B","article-title":"Comparison of the hydrophilicity of water-soluble poly(2-alkyl-2-oxazoline)s, poly(2-alkyl-2-oxazine)s and poly(2,4-dialkyl-2-oxazoline)s","volume":"15","author":"Mint","year":"2024","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jconrel.2026.114838_bb0715","doi-asserted-by":"crossref","DOI":"10.3390\/polym12091879","article-title":"Temperature behavior of aqueous solutions of poly(2-Oxazoline) homopolymer and block copolymers investigated by NMR spectroscopy and dynamic light scattering","volume":"12","author":"Konefa\u0142","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2026.114838_bb0720","doi-asserted-by":"crossref","first-page":"1700021","DOI":"10.1002\/macp.201700021","article-title":"Chain and step growth polymerizations of cyclic Imino ethers: from poly(2-oxazoline)s to poly(ester amide)s","volume":"218, (11)","author":"Kempe","year":"2017","journal-title":"Macromol. Chem. Phys."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb0725","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/ma60042a054","article-title":"A new route to optically active linear poly(propylenimine)","volume":"7","author":"Saegusa","year":"1974","journal-title":"Macromolecules"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb0730","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1039\/b921467d","article-title":"Secondary structure formation of main-chain chiral poly(2-oxazoline)s in solution","volume":"6","author":"Bloksma","year":"2010","journal-title":"Soft Matter"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0735","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1021\/acs.biomac.2c01105","article-title":"Probing the biocompatibility and immune cell association of chiral, water-soluble, bottlebrush poly(2-oxazoline)s","volume":"24","author":"Pizzi","year":"2022","journal-title":"Biomacromolecules"},{"issue":"14","key":"10.1016\/j.jconrel.2026.114838_bb0740","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1021\/acs.macromol.2c00229","article-title":"Synthesis and investigation of chiral poly(2,4-disubstituted-2-oxazoline)-based triblock copolymers, their self-assembly, and formulation with chiral and achiral drugs","volume":"55","author":"Yang","year":"2022","journal-title":"Macromolecules"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0745","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/pol.1969.160070302","article-title":"Polymerization of cyclic imino ethers. VI. X-ray study of some polyaziridines","volume":"7","author":"Litt","year":"1969","journal-title":"J. Polymer Sci. Part A-2: Polym. Phys."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0750","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/masy.201400023","article-title":"Main-chain chiral poly(2-oxazoline)s: influence of alkyl side-chain on secondary structure formation in the solid state","volume":"350","author":"Bloksma","year":"2015","journal-title":"Macromol. Symp."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114838_bb0755","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/polb.23967","article-title":"Revisiting the crystallization of poly(2-alkyl-2-oxazoline)s","volume":"54","author":"Demirel","year":"2016","journal-title":"J. Polym. Sci. B Polym. Phys."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0760","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/pola.26437","article-title":"Chiral and water-soluble poly(2-oxazoline)s","volume":"51","author":"Luxenhofer","year":"2013","journal-title":"J. Polym. Sci. A Polym. Chem."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114838_bb0765","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/pi.6426","article-title":"Poly(2-oxazoline)s: a comprehensive overview of polymer structures and their physical properties\u2014an update","volume":"71","author":"Jana","year":"2022","journal-title":"Polym. Int."},{"issue":"19","key":"10.1016\/j.jconrel.2026.114838_bb0770","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/marc.201200266","article-title":"How to modulate the chemical structure of polyoxazolines by appropriate functionalization","volume":"33","author":"Guillerm","year":"2012","journal-title":"Macromol. Rapid Commun."},{"issue":"30","key":"10.1016\/j.jconrel.2026.114838_bb0775","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1039\/D2PY00649A","article-title":"Protected amine-functional initiators for the synthesis of \u03b1-amine homo- and heterotelechelic poly(2-ethyl-2-oxazoline)s","volume":"13","author":"Mazrad","year":"2022","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jconrel.2026.114838_bb0780","doi-asserted-by":"crossref","first-page":"2000320","DOI":"10.1002\/marc.202000320","article-title":"Thioacetate-based initiators for the synthesis of thiol-end-functionalized poly(2-oxazoline)s","volume":"41, (18)","author":"Gil Alvaradejo","year":"2020","journal-title":"Macromol. Rapid Commun."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0785","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1163\/156855598X00053","article-title":"Synthesis of segmentally deuterated poly(acetyliminoethylene) lipopolymers, material for neutron scattering and NMR studies","volume":"1","author":"Kuhn","year":"1998","journal-title":"Designed Monomers Polymers"},{"issue":"16","key":"10.1016\/j.jconrel.2026.114838_bb0790","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1002\/pola.1262","article-title":"Novel functional initiators for oxazoline polymerization","volume":"39","author":"Einzmann","year":"2001","journal-title":"J. Polym. Sci. A Polym. Chem."},{"issue":"26","key":"10.1016\/j.jconrel.2026.114838_bb0795","doi-asserted-by":"crossref","first-page":"8858","DOI":"10.1021\/ma011573e","article-title":"Lipopolymers for surface functionalizations. 1. Synthesis and characterization of terminal functionalized poly(N-propionylethylenimine)s","volume":"34","author":"Jordan","year":"2001","journal-title":"Macromolecules"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0800","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/cphc.200300863","article-title":"Supported membranes with well-defined polymer tethers\u2014incorporation of cell receptors","volume":"5","author":"Purrucker","year":"2004","journal-title":"ChemPhysChem"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb0805","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/mabi.200500004","article-title":"Lipopolymers from new 2-substituted-2-oxazolines for artificial cell membrane constructs","volume":"5","author":"L\u00fcdtke","year":"2005","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2026.114838_bb0810","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.eurpolymj.2015.01.019","article-title":"Systematic investigation of alkyl sulfonate initiators for the cationic ring-opening polymerization of 2-oxazolines revealing optimal combinations of monomers and initiators","volume":"65","author":"Glassner","year":"2015","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2026.114838_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111779","article-title":"End-functionalized diblock copolymers by mix and match of poly(2-oxazoline) and polyester building blocks","volume":"184","author":"Stafast","year":"2023","journal-title":"Eur. Polym. J."},{"issue":"27","key":"10.1016\/j.jconrel.2026.114838_bb0820","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202404972","article-title":"Facile generation of Heterotelechelic poly(2-oxazoline)s towards accelerated exploration of poly(2-oxazoline)-based nanomedicine","volume":"63","author":"Van Guyse","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.114838_bb0825","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.eurpolymj.2019.07.047","article-title":"Synthetic approaches on conjugation of poly(2-oxazoline)s with vinyl based polymers","volume":"119","author":"Drain","year":"2019","journal-title":"Eur. Polym. J."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb0830","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/acs.macromol.3c02030","article-title":"Cryogels based on poly(2-oxazoline)s through development of bi- and trifunctional cross-linkers incorporating end groups with adjustable stability","volume":"57","author":"Engel","year":"2024","journal-title":"Macromolecules"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114838_bb0835","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1021\/acs.biomac.4c00651","article-title":"Tailored monoacyl poly(2-oxazoline)- and poly(2-oxazine)-lipids as PEG-lipid alternatives for stabilization and delivery of mRNA-lipid nanoparticles","volume":"25","author":"He","year":"2024","journal-title":"Biomacromolecules"},{"issue":"41","key":"10.1016\/j.jconrel.2026.114838_bb0840","doi-asserted-by":"crossref","first-page":"14323","DOI":"10.1021\/ja504390x","article-title":"Therapeutic protein\u2013polymer conjugates: advancing beyond PEGylation","volume":"136","author":"Pelegri-O\u2019Day","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"48","key":"10.1016\/j.jconrel.2026.114838_bb0845","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1039\/C5PY01280E","article-title":"Solvent-free mechanochemical synthesis of a bicyclononyne tosylate: a fast route towards bioorthogonal clickable poly(2-oxazoline)s","volume":"6","author":"Glassner","year":"2015","journal-title":"Polym. Chem."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0850","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/mabi.201500376","article-title":"Maleimide-functionalized poly(2-oxazoline)s and their conjugation to elastin-like polypeptides","volume":"16","author":"Nawroth","year":"2016","journal-title":"Macromol. Biosci."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0855","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1021\/acsbiomaterials.6b00578","article-title":"Site-specific POxylation of interleukin-4","volume":"3","author":"L\u00fchmann","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2026.114838_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2019.109246","article-title":"Poly(2-oxazoline)-protein conjugates","volume":"120","author":"Sedlacek","year":"2019","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2026.114838_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2025.113842","article-title":"Harnessing the hydrolytic stability of poly(2-oxazine) living chain-ends for direct aqueous bioconjugations","volume":"228","author":"Lusiani","year":"2025","journal-title":"Eur. Polym. J."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114838_bb0870","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1021\/acs.bioconjchem.5b00393","article-title":"Conjugation of ciprofloxacin with poly(2-oxazoline)s and polyethylene glycol via end groups","volume":"26","author":"Schmidt","year":"2015","journal-title":"Bioconjug. Chem."},{"issue":"26","key":"10.1016\/j.jconrel.2026.114838_bb0875","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1039\/C9CC00407F","article-title":"Straightforward access to biocompatible poly(2-oxazoline)-coated nanomaterials by polymerization-induced self-assembly","volume":"55","author":"Le","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2026.114838_bb0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.09.003","article-title":"Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: in vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues","volume":"146","author":"Sedlacek","year":"2017","journal-title":"Biomaterials"},{"issue":"32","key":"10.1016\/j.jconrel.2026.114838_bb0885","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1039\/D0PY00602E","article-title":"Drug\u2013polymer conjugates with dynamic cloud point temperatures based on poly(2-oxazoline) copolymers","volume":"11","author":"Park","year":"2020","journal-title":"Polym. Chem."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114838_bb0890","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1021\/bm501697t","article-title":"Side-chain cysteine-functionalized poly(2-oxazoline)s for multiple peptide conjugation by native chemical ligation","volume":"16","author":"Schmitz","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.114838_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2019.109217","article-title":"Influence of side-chain length on long-term release kinetics from poly(2-oxazoline)-drug conjugate networks","volume":"120","author":"Park","year":"2019","journal-title":"Eur. Polym. J."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0900","doi-asserted-by":"crossref","first-page":"1900500","DOI":"10.1002\/macp.201900500","article-title":"In situ polymer analogue generation of azlactone functions at poly(oxazoline)s for peptide conjugation","volume":"221","author":"Liebscher","year":"2020","journal-title":"Macromol. Chem. Phys."},{"key":"10.1016\/j.jconrel.2026.114838_bb0905","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2022.08.004","article-title":"Poly(2-oxazoline) \u2013 Ferrostatin-1 drug conjugates inhibit ferroptotic cell death","volume":"350","author":"Morrow","year":"2022","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0910","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1021\/acs.biomac.3c01106","article-title":"Schiff-Base cross-linked poly(2-oxazoline) micelle drug conjugates possess antiferroptosis activity in numerous in vitro cell models","volume":"25","author":"Morrow","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.114838_bb0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2019.109241","article-title":"Tuning drug release from polyoxazoline-drug conjugates","volume":"120","author":"Harris","year":"2019","journal-title":"Eur. Polym. J."},{"issue":"28","key":"10.1016\/j.jconrel.2026.114838_bb0920","doi-asserted-by":"crossref","first-page":"24734","DOI":"10.1021\/jacs.5c06232","article-title":"Distal C(sp3)-H amidation via Ind*RhIII catalyzed nitrene transfer","volume":"147","author":"Ross","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"32","key":"10.1016\/j.jconrel.2026.114838_bb0925","doi-asserted-by":"crossref","first-page":"12498","DOI":"10.1021\/jacs.9b06009","article-title":"Living polymerization of 2-ethylthio-2-oxazoline and postpolymerization diversification","volume":"141","author":"Wu","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0930","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00255349","article-title":"Kinetics and mechanism of cationic polymerization of 5-methyl-2-oxazoline. Concurrent propagation through ionic and covalent species with methyl iodide initiator","volume":"11","author":"Kobayashi","year":"1984","journal-title":"Polym. Bull."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0935","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00255348","article-title":"Cationic polymerization of 5-methyl-2-oxazoline and alkaline hydrolysis of product polymer to linear poly(propylenimine)","volume":"11","author":"Kobayashi","year":"1984","journal-title":"Polym. Bull."},{"key":"10.1016\/j.jconrel.2026.114838_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.112964","article-title":"Influence of chirality on protein corona formation of low-fouling chiral poly(2-oxazoline) coated nanoparticles","volume":"210","author":"Pizzi","year":"2024","journal-title":"Eur. Polym. J."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114838_bb0945","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jbm.a.30818","article-title":"Thermodynamic perspectives on the molecular mechanisms providing protein adsorption resistance that include protein-surface interactions","volume":"78A","author":"Latour","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb0950","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0142-9612(91)90193-E","article-title":"Solution technique to incorporate polyethylene oxide and other water-soluble polymers into surfaces of polymeric biomaterials","volume":"12","author":"Desai","year":"1991","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb0955","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/1282\/1\/012069","article-title":"Hemocompatibility study of surface-attached antibiofouling polymer monolayers","volume":"1282","author":"Pidhatika","year":"2019","journal-title":"J. Phys. Conf. Ser."},{"key":"10.1016\/j.jconrel.2026.114838_bb0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120843","article-title":"Interactions of core cross-linked poly(2-oxazoline) and poly(2-oxazine) micelles with immune cells in human blood","volume":"274","author":"Leiske","year":"2021","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0965","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1021\/acs.biomac.4c01587","article-title":"Cyclic poly(2-methyl-2-oxazoline)-lipid conjugates are good alternatives to poly(ethylene glycol)-lipids for lipid nanoparticle mRNA formulation","volume":"26","author":"Golba","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.114838_bb0970","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154-155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114838_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtla.2020.100763","article-title":"Degradation and excretion of poly(2-oxazoline) based hemostatic materials","volume":"12","author":"Boerman","year":"2020","journal-title":"Materialia"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb0980","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/acs.macromol.7b02665","article-title":"POx as an alternative to PEG? A hydrodynamic and light scattering study","volume":"51","author":"Grube","year":"2018","journal-title":"Macromolecules"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114838_bb0985","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/mabi.201200017","article-title":"Poly(2-ethyl-2-oxazoline) as alternative for the stealth polymer poly(ethylene glycol): comparison of in vitro cytotoxicity and hemocompatibility","volume":"12","author":"Bauer","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2026.114838_bb0990","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2016.05.048","article-title":"\u03bcPET imaging of the pharmacokinetic behavior of medium and high molar mass 89Zr-labeled poly(2-ethyl-2-oxazoline) in comparison to poly(ethylene glycol)","volume":"235","author":"Wyffels","year":"2016","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb0995","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jconrel.2007.02.015","article-title":"Synthesis, biodistribution and excretion of radiolabeled poly(2-alkyl-2-oxazoline)s","volume":"119","author":"Gaertner","year":"2007","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb1000","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1021\/acs.biomac.6b01392","article-title":"The label matters: \u03bcPET imaging of the biodistribution of low molar mass 89Zr and 18F-labeled poly(2-ethyl-2-oxazoline)","volume":"18","author":"Glassner","year":"2017","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb1005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1021\/bc00030a001","article-title":"New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes","volume":"5","author":"Woodle","year":"1994","journal-title":"Bioconjug. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb1010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/js9504043","article-title":"Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes\u00a7","volume":"85","author":"Zalipsky","year":"1996","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114838_bb1015","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/acs.biomac.0c00765","article-title":"Hyperbranched Poly(2-oxazoline)s and poly(ethylene glycol): A structure\u2013activity comparison of biodistribution","volume":"21","author":"Humphries","year":"2020","journal-title":"Biomacromolecules"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114838_bb1020","doi-asserted-by":"crossref","first-page":"13739","DOI":"10.1021\/acsnano.0c06033","article-title":"Controlling the biological fate of micellar nanoparticles: balancing stealth and targeting","volume":"14","author":"Sivaram","year":"2020","journal-title":"ACS Nano"},{"issue":"27","key":"10.1016\/j.jconrel.2026.114838_bb1025","doi-asserted-by":"crossref","first-page":"2201993","DOI":"10.1002\/smll.202201993","article-title":"Block length-dependent protein fouling on poly(2-oxazoline)-based polymersomes: influence on macrophage association and circulation behavior","volume":"18","author":"Najer","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114838_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113564","article-title":"Tuning polymer\u2013blood and polymer\u2013cytoplasm membrane interactions by manipulating the architecture of poly(2-oxazoline) triblock copolymers","volume":"231","author":"Lobaz","year":"2023","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2026.114838_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2021.110447","article-title":"Poly(2-ethyl-2-oxazoline) bottlebrushes: how nanomaterial dimensions can influence biological interactions","volume":"151","author":"Pizzi","year":"2021","journal-title":"Eur. Polym. J."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114838_bb1040","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.1021\/acsnano.7b04855","article-title":"Bridging bio-nano science and cancer nanomedicine","volume":"11","author":"Bj\u00f6rnmalm","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114838_bb1045","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jss.2024.03.033","article-title":"Clinical safety and performance of GATT-patch for hemostasis in minimal to moderate bleeding during open liver surgery","volume":"298","author":"de Wilt","year":"2024","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.jconrel.2026.114838_bb1050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2015.02.024","article-title":"Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation","volume":"208","author":"He","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114838_bb1055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.actbio.2015.05.021","article-title":"Enhanced antitumor efficacy by cyclic RGDyK-conjugated and paclitaxel-loaded pH-responsive polymeric micelles","volume":"23","author":"Gao","year":"2015","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb1060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1039\/C4NR05738D","article-title":"PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking","volume":"7","author":"Gao","year":"2015","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb1065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/bc5004718","article-title":"Poly(2-ethyl-2-oxazoline)\u2013doxorubicin conjugate-based dual endosomal pH-sensitive micelles with enhanced antitumor efficacy","volume":"26","author":"Li","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2026.114838_bb1070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.actbio.2015.01.010","article-title":"pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(d,l-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor","volume":"17","author":"Zhao","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114838_bb1075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biomaterials.2016.06.002","article-title":"A high capacity polymeric micelle of paclitaxel: implication of high dose drug therapy to safety and in vivo anti-cancer activity","volume":"101","author":"He","year":"2016","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.jconrel.2026.114838_bb1080","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1242\/dev.139022","article-title":"ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation","volume":"143","author":"Lang","year":"2016","journal-title":"Development"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114838_bb1085","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201700206","article-title":"Cisplatin-rich polyoxazoline\u2013poly(aspartic acid) supramolecular nanoparticles","volume":"17","author":"Zhang","year":"2017","journal-title":"Macromol. Biosci."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114838_bb1090","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1021\/acsami.6b14464","article-title":"Supramolecular amphiphilic polymer-based micelles with seven-armed polyoxazoline coating for drug delivery","volume":"9","author":"Zhang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb1095","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1080\/10717544.2017.1402218","article-title":"Reduction-responsive PEtOz-SS-PCL micelle with tailored size to overcome blood\u2013brain barrier and enhance doxorubicin antiglioma effect","volume":"24","author":"Li","year":"2017","journal-title":"Drug Deliv."},{"issue":"C","key":"10.1016\/j.jconrel.2026.114838_bb1100","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.eurpolymj.2016.09.052","article-title":"Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson\u2019s disease \u2013 proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications","volume":"88","author":"Moreadith","year":"2017","journal-title":"Eur. Polym. J."},{"issue":"32","key":"10.1016\/j.jconrel.2026.114838_bb1105","doi-asserted-by":"crossref","first-page":"22316","DOI":"10.18632\/oncotarget.24806","article-title":"Tumor targeting with pH-responsive poly(2-oxazoline)-based nanogels for metronomic doxorubicin treatment","volume":"9","author":"Hoelzer","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb1110","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1021\/acsnano.7b07878","article-title":"Drug combination synergy in worm-like polymeric micelles improves treatment outcome for Small cell and non-small cell lung cancer","volume":"12","author":"Wan","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114838_bb1115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.05.019","article-title":"Nanoparticulate delivery of irinotecan active metabolite (SN38) in murine colorectal carcinoma through conjugation to poly (2-ethyl 2-oxazoline)-b-poly (L-glutamic acid) double hydrophilic copolymer","volume":"136","author":"Salmanpour","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114838_bb1120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.10.032","article-title":"Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments","volume":"192","author":"Wan","year":"2019","journal-title":"Biomaterials"},{"issue":"25","key":"10.1016\/j.jconrel.2026.114838_bb1125","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba5542","article-title":"High-capacity poly(2-oxazoline) formulation of TLR 7\/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma","volume":"6","author":"Vinod","year":"2020","journal-title":"Sci. Adv."},{"issue":"15","key":"10.1016\/j.jconrel.2026.114838_bb1130","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1021\/acs.macromol.0c01228","article-title":"Fluorinated water-soluble poly(2-oxazoline)s as highly sensitive 19F MRI contrast agents","volume":"53","author":"Sedlacek","year":"2020","journal-title":"Macromolecules"},{"issue":"16","key":"10.1016\/j.jconrel.2026.114838_bb1135","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1002\/anie.202000505","article-title":"Poly(2-oxazoline)-based functional peptide mimics: eradicating MRSA infections and persisters while alleviating antimicrobial resistance","volume":"59","author":"Zhou","year":"2020","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb1140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1208\/s12249-020-1619-1","article-title":"Thermosensitive hydrogel based on poly(2-ethyl-2-oxazoline)\u2013Poly(D,L-lactide)\u2013poly(2-ethyl-2-oxazoline) for sustained Salmon calcitonin delivery","volume":"21","author":"Wang","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2026.114838_bb1145","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.2147\/IJN.S298093","article-title":"Anti-cancer activity based on the high docetaxel loaded poly(2-oxazoline)s micelles","volume":"16","author":"Xu","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114838_bb1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121140","article-title":"Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane\u00ae in rodent and non-human primate models using a stable isotope tracer assay","volume":"278","author":"Hwang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114838_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2020.102345","article-title":"Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity","volume":"32","author":"Hwang","year":"2021","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114838_bb1160","first-page":"571","article-title":"Nucleobase-crosslinked poly(2-oxazoline) nanoparticles as paclitaxel carriers with enhanced stability and ultra-high drug loading capacity for breast cancer therapy","volume":"17","author":"Dong","year":"2022","journal-title":"Asian J. Pharmaceut. Sci."},{"key":"10.1016\/j.jconrel.2026.114838_bb1165","article-title":"Poly(2-oxazoline)-magnetite NanoFerrogels: magnetic field responsive theranostic platform for cancer drug delivery and imaging","volume":"39","author":"Seo","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114838_bb1170","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101884","article-title":"High-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple negative breast cancer","volume":"51","author":"Lim","year":"2023","journal-title":"Nano Today"},{"issue":"25","key":"10.1016\/j.jconrel.2026.114838_bb1175","doi-asserted-by":"crossref","first-page":"2300299","DOI":"10.1002\/advs.202300299","article-title":"Polyoxazoline-based nanovaccine synergizes with tumor-associated macrophage targeting and anti-PD-1 immunotherapy against solid tumors","volume":"10","author":"Matos","year":"2023","journal-title":"Adv. Sci."},{"issue":"47","key":"10.1016\/j.jconrel.2026.114838_bb1180","doi-asserted-by":"crossref","first-page":"25753","DOI":"10.1021\/jacs.3c09240","article-title":"Peptide-mimicking poly(2-oxazoline)s possessing potent antifungal activity and BBB penetrating property to treat invasive infections and meningitis","volume":"145","author":"Jiang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"33","key":"10.1016\/j.jconrel.2026.114838_bb1185","doi-asserted-by":"crossref","first-page":"10114","DOI":"10.1021\/acs.nanolett.4c02196","article-title":"Uniform polymeric nanovaccine platform for improving the availability and efficacy of neoantigen peptides","volume":"24","author":"Chen","year":"2024","journal-title":"Nano Lett."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114838_bb1190","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.scib.2024.01.039","article-title":"Hit-and-run vaccine system that overcomes limited neoantigen epitopes for efficient broad antitumor response","volume":"69","author":"Chen","year":"2024","journal-title":"Sci. Bull."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb1195","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/s41564-024-01662-5","article-title":"A dual-targeting antifungal is effective against multidrug-resistant human fungal pathogens","volume":"9","author":"Zhou","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jconrel.2026.114838_bb1200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fddev.2024.1383038","article-title":"Poly(2-methyl-2-oxazoline) as a polyethylene glycol alternative for lipid nanoparticle formulation","volume":"4","author":"van Zyl","year":"2024","journal-title":"Front. Drug Deliv."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114838_bb1205","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202300568","article-title":"Neutral block copolymer assisted gene delivery using hydrodynamic limb vein injection","volume":"24","author":"Guen","year":"2024","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2026.114838_bb1210","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jmst.2024.06.041","article-title":"Peptide-mimicking poly(2-oxazoline) displaying potent antibacterial and antibiofilm activities against multidrug-resistant gram-positive pathogenic bacteria","volume":"214","author":"Cong","year":"2025","journal-title":"J. Mater. Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.114838_bb1215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.106492","article-title":"Mucoadhesive gellan gum\/poly(2-ethyl-2-oxazoline) films for ocular delivery of pilocarpine hydrochloride","volume":"104","author":"Abilova","year":"2025","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.114838_bb1220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139153","article-title":"Tellurium nanoparticles and fucoidan-loaded dissolvable microneedles for combined photothermal therapy and anti-angiogenesis in melanoma treatment","volume":"292","author":"Ye","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.114838_bb1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.162443","article-title":"Novel polymersomes based on poly(2-methyl-2-oxazoline) polymers with excellent pharmacokinetic behavior and antitumor effect by modulating dynamic protein corona","volume":"512","author":"Cai","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"801","key":"10.1016\/j.jconrel.2026.114838_bb1230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adl4870","article-title":"A host defense peptide\u2013mimicking prodrug activated by drug-resistant Gram-negative bacterial infections","volume":"17","author":"Xie","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.114838_bb1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.164753","article-title":"A copper-doped mesoporous nanoplatform with dual enzyme-mimic activities for amplified cuproptosis and immune response","volume":"519","author":"Xu","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb1240","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1021\/nn406388t","article-title":"Drug-induced morphology switch in drug delivery systems based on poly(2-oxazoline)s","volume":"8","author":"Schulz","year":"2014","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb1245","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/mp300496x","article-title":"Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo","volume":"10","author":"Tong","year":"2013","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114838_bb1250","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1007\/s11095-014-1397-0","article-title":"The bifunctional liposomes constructed by poly(2-ethyl-oxazoline)-cholesteryl methyl carbonate: an effectual approach to enhance liposomal circulation time, pH-sensitivity and endosomal escape","volume":"31","author":"Xu","year":"2014","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114838_bb1255","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.nano.2015.02.004","article-title":"Delivering nanomedicines to patients: a practical guide","volume":"11","author":"Eaton","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"18","key":"10.1016\/j.jconrel.2026.114838_bb1260","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1016\/j.biomaterials.2010.02.057","article-title":"Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs","volume":"31","author":"Luxenhofer","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114838_bb1265","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.2147\/IJN.S298093","article-title":"Anti-cancer activity based on the high docetaxel loaded polys micelles","volume":"16","author":"Xu","year":"2021","journal-title":"Int. J. Nanomedicine"},{"issue":"9","key":"10.1016\/j.jconrel.2026.114838_bb1270","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1021\/acs.bioconjchem.9b00456","article-title":"Insights into active targeting of nanoparticles in drug delivery: advances in clinical studies and design considerations for cancer nanomedicine","volume":"30","author":"Pearce","year":"2019","journal-title":"Bioconjug. Chem."},{"issue":"696","key":"10.1016\/j.jconrel.2026.114838_bb1275","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm1262","article-title":"Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia","volume":"15","author":"Moles","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"42","key":"10.1016\/j.jconrel.2026.114838_bb1280","doi-asserted-by":"crossref","first-page":"29021","DOI":"10.1021\/acsnano.4c09919","article-title":"Patient-specific nanoparticle targeting in human leukemia blood","volume":"18","author":"Ju","year":"2024","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb1285","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202105063","article-title":"Bioactive synthetic polymers","volume":"34","author":"Jung","year":"2022","journal-title":"Adv. Mater."},{"issue":"17","key":"10.1016\/j.jconrel.2026.114838_bb1290","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1016\/j.biomaterials.2010.02.044","article-title":"Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering","volume":"31","author":"Zhu","year":"2010","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb1295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1021\/acs.biomac.7b01279","article-title":"Poly(2-oxazoline)\u2013pterostilbene block copolymer nanoparticles for dual-anticancer drug delivery","volume":"19","author":"Romio","year":"2018","journal-title":"Biomacromolecules"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114838_bb1305","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/cmdc.202000530","article-title":"Peptide-mimicking poly(2-oxazoline)s displaying potent antimicrobial properties","volume":"16","author":"Zhou","year":"2021","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb1310","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2180-13-192","article-title":"The antimicrobial lysine-peptoid hybrid LP5 inhibits DNA replication and induces the SOS response in Staphylococcus aureus","volume":"13","author":"Gottschalk","year":"2013","journal-title":"BMC Microbiol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb1315","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/1574-6976.12077","article-title":"SOS, the formidable strategy of bacteria against aggressions","volume":"38","author":"Baharoglu","year":"2014","journal-title":"FEMS Microbiol. Rev."},{"issue":"34","key":"10.1016\/j.jconrel.2026.114838_bb1320","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1039\/D1DT01358K","article-title":"Synergy of DNA intercalation and catalytic activity of a copper complex towards improved polymerase inhibition and cancer cell cytotoxicity","volume":"50","author":"Romo","year":"2021","journal-title":"Dalton Trans."},{"issue":"24","key":"10.1016\/j.jconrel.2026.114838_bb1325","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1111\/febs.12558","article-title":"Naproxen intercalates with DNA and causes photocleavage through ROS generation","volume":"280","author":"Husain","year":"2013","journal-title":"FEBS J."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114838_bb1330","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.3390\/ijms22094642","article-title":"The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies","volume":"22","author":"Juan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114838_bb1335","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1021\/acs.biomac.1c00046","article-title":"Poly(2-allylamidopropyl-2-oxazoline)-based hydrogels: from accelerated gelation kinetics to in vivo compatibility in a murine subdermal implant model","volume":"22","author":"Dargaville","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.114838_bb1340","doi-asserted-by":"crossref","first-page":"120","DOI":"10.22203\/eCM.v051a07","article-title":"Evaluation of bone adhesive barrier membranes for guided bone regeneration: an experimental study in rats","volume":"51","author":"Poos","year":"2025","journal-title":"Eur. Cells Mater."},{"key":"10.1016\/j.jconrel.2026.114838_bb1345","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtla.2022.101517","article-title":"Novel alendronate and NHS-ester functionalized poly(2-oxazoline)s bone adhesive barrier membranes for guided bone regeneration: prototype selection and experimental model comparison","volume":"24","author":"van Erk","year":"2022","journal-title":"Materialia"},{"issue":"29","key":"10.1016\/j.jconrel.2026.114838_bb1350","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1039\/D1TB00502B","article-title":"Bone-adhesive barrier membranes based on alendronate-functionalized poly(2-oxazoline)s","volume":"9","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2026.114838_bb1355","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1874210601408010056","article-title":"Mechanisms of guided bone regeneration: a review","volume":"8","author":"Liu","year":"2014","journal-title":"Open Dent. J."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb1360","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-10-81","article-title":"The role of barrier membranes for guided bone regeneration and restoration of large bone defects: current experimental and clinical evidence","volume":"10","author":"Dimitriou","year":"2012","journal-title":"BMC Med."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114838_bb1365","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1021\/acs.biomac.9b00104","article-title":"Alendronate-functionalized poly(2-oxazoline)s with tunable affinity for calcium cations","volume":"20","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2019","journal-title":"Biomacromolecules"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114838_bb1370","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1021\/acs.biomac.7b00683","article-title":"Next generation hemostatic materials based on NHS-Ester functionalized poly(2-oxazoline)s","volume":"18","author":"Boerman","year":"2017","journal-title":"Biomacromolecules"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114838_bb1375","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/mds.25625","article-title":"Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit","volume":"28","author":"Eskow Jaunarajs","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jconrel.2026.114838_bb1380","author":"Multi-center","year":"2015"},{"key":"10.1016\/j.jconrel.2026.114838_bb1385","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.eurpolymj.2016.09.052","article-title":"Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson\u2019s disease \u2013 proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications","volume":"88","author":"Moreadith","year":"2017","journal-title":"Eur. Polym. J."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb1390","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/mds.28027","article-title":"Once-weekly subcutaneous delivery of polymer-linked rotigotine (SER-214) provides continuous plasma levels in Parkinson\u2019s disease patients","volume":"35","author":"Olanow","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jconrel.2026.114838_bb1395","series-title":"A Prospective, Multicenter, Single-Arm, Clinical Investigation Evaluating the Safety and Performance of GATT-Patch for Hemostasis during Open Liver Surgery","year":"2021"},{"key":"10.1016\/j.jconrel.2026.114838_bb1400","series-title":"A Prospective, Multicenter, Randomized Clinical Investigation Evaluating the Safety and Efficacy of GATT-Patch Versus TachoSil for Hemostasis During Open Liver Surgery","year":"2022"},{"key":"10.1016\/j.jconrel.2026.114838_bb1405","first-page":"6","article-title":"Proof-of-principle of a lung sealant based on functionalized polyoxazolines: experiments in an ovine acute aerostasis model","volume":"38","author":"Hermans","year":"2024","journal-title":"Interdiscipl. CardioVasc. Thoracic Surg."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb1410","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd.2017.244","article-title":"Impact of a five-dimensional framework on R&D productivity at AstraZeneca","volume":"17","author":"Morgan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114838_bb1415","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.nantod.2016.05.006","article-title":"Zwitterionic polymer-protein conjugates reduce polymer-specific antibody response","volume":"11","author":"Liu","year":"2016","journal-title":"Nano Today"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114838_bb1420","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/acs.nanolett.0c01713","article-title":"Zwitterionic nanoconjugate enables safe and efficient lymphatic drug delivery","volume":"20","author":"Li","year":"2020","journal-title":"Nano Lett."},{"issue":"4909","key":"10.1016\/j.jconrel.2026.114838_bb1425","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.2658060","article-title":"The role of somatic hypermutation in the generation of antibody diversity","volume":"244","author":"French Deborah","year":"1989","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114838_bb1430","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1462-5822.2005.00591.x","article-title":"Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens","volume":"7","author":"Cobb","year":"2005","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.jconrel.2026.114838_bb1435","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.addr.2020.04.006","article-title":"Immunology of carbohydrate-based vaccines","volume":"165-166","author":"Khatun","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb1440","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"issue":"16","key":"10.1016\/j.jconrel.2026.114838_bb1445","doi-asserted-by":"crossref","first-page":"2411354","DOI":"10.1002\/smll.202411354","article-title":"Poly(2-ethyl-2-oxazoline) (POx) as poly(ethylene glycol) (PEG)-lipid substitute for lipid nanoparticle formulations","volume":"21","author":"Holick","year":"2025","journal-title":"Small"},{"issue":"25","key":"10.1016\/j.jconrel.2026.114838_bb1450","doi-asserted-by":"crossref","first-page":"21538","DOI":"10.1021\/jacs.5c02716","article-title":"Isomerization of poly(ethylene glycol): a strategy for the evasion of anti-PEG antibody recognition","volume":"147","author":"Dreier","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"32","key":"10.1016\/j.jconrel.2026.114838_bb1455","doi-asserted-by":"crossref","first-page":"34577","DOI":"10.1021\/acsomega.4c02655","article-title":"Impact of the hydrophilicity of poly(sarcosine) on poly(ethylene glycol) (PEG) for the suppression of anti-PEG antibody binding","volume":"9","author":"Maiti","year":"2024","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114838_bb1460","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1039\/D4BM01541J","article-title":"Zwitterionic polymer with minimal reactivity against PEG antibodies to enhance the therapeutic effects of cytokine-targeting DNA aptamer","volume":"13","author":"Cho","year":"2025","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114838_bb1465","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1038\/s41467-025-57648-2","article-title":"Species differences in opsonization and phagocyte recognition of preclinical poly-2-alkyl-2-oxazoline-coated nanoparticles","volume":"16","author":"Tavano","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114838_bb1470","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2019.109258","article-title":"Poly(2-oxazoline) macromonomers as building blocks for functional and biocompatible polymer architectures","volume":"121","author":"Pizzi","year":"2019","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2026.114838_bb1475","doi-asserted-by":"crossref","DOI":"10.1016\/j.progpolymsci.2020.101209","article-title":"Controlled radical polymerization in dispersed systems for biological applications","volume":"102","author":"Gurnani","year":"2020","journal-title":"Prog. Polym. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:10:05Z","timestamp":1793945405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926002403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":294,"alternative-id":["S0168365926002403"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114838","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poly(2-oxazoline) and poly(2-oxazine)-based nanomedicines: Advancements, opportunities and challenges","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114838","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114838"}}